{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:57:20Z","timestamp":1772121440352,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"am","delay-in-days":264,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH097446"],"award-info":[{"award-number":["MH097446"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS051195"],"award-info":[{"award-number":["NS051195"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS080064"],"award-info":[{"award-number":["NS080064"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS087662"],"award-info":[{"award-number":["NS087662"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS081735"],"award-info":[{"award-number":["NS081735"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS056359"],"award-info":[{"award-number":["NS056359"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["AR140209"],"award-info":[{"award-number":["AR140209"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["206026"],"award-info":[{"award-number":["206026"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA017938"],"award-info":[{"award-number":["AA017938"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neuropharm.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T01:22:30Z","timestamp":1476580950000},"page":"314-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"PA","title":["Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase\u00a0C-dependent mechanism"],"prefix":"10.1016","volume":"113","author":[{"given":"Amit","family":"Modgil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasa L.","family":"Parakala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Ackley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3973-3143","authenticated-orcid":false,"given":"Paul A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.10.010_bib1","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1073\/pnas.1403285111","article-title":"Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors","volume":"111","author":"Abramian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib2","doi-asserted-by":"crossref","first-page":"41795","DOI":"10.1074\/jbc.M110.149229","article-title":"Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition","volume":"285","author":"Abramian","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2014.09.021","article-title":"Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABAA receptors","volume":"88","author":"Adams","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.010_bib4","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib5","doi-asserted-by":"crossref","first-page":"19613","DOI":"10.1074\/jbc.274.28.19613","article-title":"A\u00a0significant part of native gamma-aminobutyric AcidA receptors containing alpha4 subunits do not contain gamma or delta subunits","volume":"274","author":"Bencsits","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib6","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1021\/acs.jmedchem.5b00032","article-title":"Neuroactive steroids. 1. Positive allosteric modulators of the (gamma-aminobutyric acid)(A) receptor: structure-activity relationships of heterocyclic substitution at C-21","volume":"58","author":"Botella","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.010_bib8","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1111\/ejn.12352","article-title":"Protein kinase C regulates tonic GABA(A) receptor-mediated inhibition in the hippocampus and thalamus","volume":"38","author":"Bright","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib9","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.0307231101","article-title":"Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors","volume":"101","author":"Caraiscos","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib10","doi-asserted-by":"crossref","first-page":"15230","DOI":"10.1073\/pnas.0604304103","article-title":"GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol","volume":"103","author":"Chandra","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cercor\/bhn159","article-title":"Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome","volume":"19","author":"Curia","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2016.10.010_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tins.2007.06.003","article-title":"The GABAA receptor: a novel target for treatment of fragile X?","volume":"30","author":"D'Hulst","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2005.07.017","article-title":"Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model","volume":"21","author":"Gantois","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuron.2007.11.002","article-title":"Activation of GABAA receptors: views from outside the synaptic cleft","volume":"56","author":"Glykys","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.010_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nn1813","article-title":"A\u00a0new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol","volume":"10","author":"Glykys","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1113\/jphysiol.2007.146746","article-title":"The expression of GABAA beta subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells","volume":"586","author":"Herd","year":"2008","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1523\/JNEUROSCI.3606-03.2004","article-title":"Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability","volume":"24","author":"Jovanovic","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib18","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1073\/pnas.0506653102","article-title":"Phospho-dependent binding of the clathrin AP2 adaptor complex to GABAA receptors regulates the efficacy of inhibitory synaptic transmission","volume":"102","author":"Kittler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib19","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1523\/JNEUROSCI.5475-12.2013","article-title":"Enhanced tonic inhibition influences the hypnotic and amnestic actions of the intravenous anesthetics etomidate and propofol","volume":"33","author":"Kretschmannova","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","article-title":"GABA(A)R plasticity during pregnancy: relevance to postpartum depression","volume":"59","author":"Maguire","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.010_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1176\/appi.ajp.2008.08101484","article-title":"Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"166","author":"Maldonado-Aviles","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.10.010_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuint.2007.10.007","article-title":"Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease","volume":"52","author":"Mitchell","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1113\/jphysiol.2006.117952","article-title":"Extrasynaptic alphabeta subunit GABAA receptors on rat hippocampal pyramidal neurons","volume":"577","author":"Mortensen","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib24","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1152\/jn.2002.87.5.2624","article-title":"Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells","volume":"87","author":"Nusser","year":"2002","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib25","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fncel.2014.00268","article-title":"New perspectives in neurosteroid action: open questions for future research","volume":"8","author":"Rupprecht","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tins.2004.03.005","article-title":"Tonically active GABA A receptors: modulating gain and maintaining the tone","volume":"27","author":"Semyanov","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.4346-07.2008","article-title":"Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus","volume":"28","author":"Terunuma","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.010_bib29","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1073\/pnas.1514657112","article-title":"Compromising the phosphodependent regulation of the GABAAR beta3 subunit reproduces the core phenotypes of autism spectrum disorders","volume":"112","author":"Vien","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816304609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816304609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:46:25Z","timestamp":1758437185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816304609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":29,"alternative-id":["S0028390816304609"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726852378.793535352","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726852378.793560285","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase\u00a0C-dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}